Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Deficiency of FRMD5 results in neurodevelopmental dysfunction and autistic-like behavior in mice


The pathophysiology of autism spectrum disorders (ASDs) is causally linked to postsynaptic scaffolding proteins, as evidenced by numerous large-scale genomic studies [1, 2] and in vitro and in vivo neurobiological studies of mutations in animal models [3, 4]. However, due to the distinct phenotypic and genetic heterogeneity observed in ASD patients, individual mutation genes account for only a small proportion (<2%) of cases [1, 5]. Recently, a human genetic study revealed a correlation between de novo variants in FERM domain-containing-5 (FRMD5) and neurodevelopmental abnormalities [6]. In this study, we demonstrate that deficiency of the scaffolding protein FRMD5 leads to neurodevelopmental dysfunction and ASD-like behavior in mice. FRMD5 deficiency results in morphological abnormalities in neurons and synaptic dysfunction in mice. Frmd5-deficient mice display learning and memory dysfunction, impaired social function, and increased repetitive stereotyped behavior. Mechanistically, tandem mass tag (TMT)-labeled quantitative proteomics revealed that FRMD5 deletion affects the distribution of synaptic proteins involved in the pathological process of ASD. Collectively, our findings delineate the critical role of FRMD5 in neurodevelopment and ASD pathophysiology, suggesting potential therapeutic implications for the treatment of ASD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Knockout of Frmd5 leads to ASD-like behavioral abnormalities in mice.
Fig. 2: Knockout of Frmd5 leads to abnormal dendritic branching in the basal CA1 region and abnormal spine morphology.
Fig. 3: Knockout of Frmd5 leads to increased intrinsic excitability in granule cells of the DG.
Fig. 4: Molecular changes in the synaptosome of Frmd5−/− mice.

Similar content being viewed by others

Data availability

Data from this study are available from the authors upon reasonable request.


  1. Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Autism spectrum disorder. Lancet. 2018;392:508–20.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Lord C, Bishop SL. Recent advances in autism research as reflected in DSM-5 criteria for autism spectrum disorder. Annu Rev Clin Psychol. 2015;11:53–70.

    Article  PubMed  Google Scholar 

  3. Baribeau D, Anagnostou E. Novel treatments for autism spectrum disorder based on genomics and systems biology. Pharm Ther. 2022;230:107939

    Article  CAS  Google Scholar 

  4. Jiang C-C, Lin L-S, Long S, Ke X-Y, Fukunaga K, Lu Y-M, et al. Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications. Signal Transduct Target Ther. 2022;7:229

    Article  PubMed  PubMed Central  Google Scholar 

  5. Shaw KA, McArthur D, Hughes MM, Bakian AV, Lee L-C, Pettygrove S, et al. Progress and disparities in early identification of autism spectrum disorder: autism and developmental disabilities monitoring network, 2002-2016. J Am Acad Child Adolesc Psychiatry. 2022;61:905–14.

    Article  PubMed  Google Scholar 

  6. Chung C, Shin W, Kim E. Early and late corrections in mouse models of autism spectrum disorder. Biol Psychiatry. 2022;91:934–44.

    Article  CAS  PubMed  Google Scholar 

  7. Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet. 2007;39:25–27.

    Article  CAS  PubMed  Google Scholar 

  8. Shcheglovitov A, Shcheglovitova O, Yazawa M, Portmann T, Shu R, Sebastiano V, et al. SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature. 2013;503:267–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Tatavarty V, Torrado Pacheco A, Groves Kuhnle C, Lin H, Koundinya P, Miska NJ et al. Autism-associated Shank3 is essential for homeostatic compensation in rodent V1. Neuron. 2020;106,

  10. Bourgeron T. From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat Rev Neurosci. 2015;16:551–63.

    Article  CAS  PubMed  Google Scholar 

  11. Wang T, Pei X, Zhan J, Hu J, Yu Y, Zhang H. FERM-containing protein FRMD5 is a p120-catenin interacting protein that regulates tumor progression. FEBS Lett. 2012;586:3044–50.

    Article  CAS  PubMed  Google Scholar 

  12. Brázdová M, Quante T, Tögel L, Walter K, Loscher C, Tichý V, et al. Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences. Nucleic Acids Res. 2009;37:1486–1500.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Lu S, Ma M, Mao X, Bacino CA, Jankovic J, Sutton VR, et al. De novo variants in FRMD5 are associated with developmental delay, intellectual disability, ataxia, and abnormalities of eye movement. Am J Hum Genet. 2022;109:1932–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, Rajan D, et al. DECIPHER: Database of chromosomal imbalance and phenotype in humans using ensembl resources. Am J Hum Genet. 2009;84:524–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Peca J, Feliciano C, Ting JT, Wang W, Wells MF, Venkatraman TN, et al. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature. 2011;472:437–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Monteiro P, Feng G. SHANK proteins: roles at the synapse and in autism spectrum disorder. Nat Rev Neurosci. 2017;18:147–57.

    Article  CAS  PubMed  Google Scholar 

  17. Lin YC, Frei JA, Kilander MB, Shen W, Blatt GJ. A subset of autism-associated genes regulate the structural stability of neurons. Front Cell Neurosci. 2016;10:263

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Groza T, Gomez FL, Mashhadi HH, Muñoz-Fuentes V, Gunes O, Wilson R, et al. The International Mouse Phenotyping Consortium: comprehensive knockout phenotyping underpinning the study of human disease. Nucleic Acids Res. 2022;51:D1038–D1045.

    Article  CAS  PubMed Central  Google Scholar 

  19. Iakoucheva LM, Muotri AR, Sebat J. Getting to the cores of autism. Cell. 2019;178:1287–98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Quesnel-Vallières M, Weatheritt RJ, Cordes SP, Blencowe BJ. Autism spectrum disorder: insights into convergent mechanisms from transcriptomics. Nat Rev Genet. 2019;20:51–63.

    Article  CAS  PubMed  Google Scholar 

  21. Mullins C, Fishell G, Tsien RW. Unifying views of autism spectrum disorders: a consideration of autoregulatory feedback loops. Neuron. 2016;89:1131–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Moretto E, Murru L, Martano G, Sassone J, Passafaro M. Glutamatergic synapses in neurodevelopmental disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2018;84:328–42.

    Article  CAS  PubMed  Google Scholar 

  23. Lee E, Lee J, Kim E. Excitation/Inhibition imbalance in animal models of autism spectrum disorders. Biol Psychiatry. 2017;81:838–47.

    Article  PubMed  Google Scholar 

  24. Ecker C, Bookheimer SY, Murphy DG. Neuroimaging in autism spectrum disorder: brain structure and function across the lifespan. Lancet Neurol. 2015;14:1121–34.

    Article  PubMed  Google Scholar 

  25. Lewis JD, Evans AC, Pruett JR, Botteron K, Zwaigenbaum L, Estes A, et al. Network inefficiencies in autism spectrum disorder at 24 months. Transl Psychiatry. 2014;4:e388

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. O’Reilly C, Lewis JD, Elsabbagh M. Is functional brain connectivity atypical in autism? A systematic review of EEG and MEG studies. PLoS One. 2017;12:e0175870

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Khoshbakht S, Beheshtian M, Fattahi Z, Bazazzadegan N, Parsimehr E, Fadaee M, et al. CEP104 and CEP290; genes with ciliary functions cause intellectual disability in multiple families. Arch Iran Med. 2021;24:364–73.

    Article  PubMed  Google Scholar 

  28. Silverman JL, Yang M, Lord C, Crawley JN. Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci. 2010;11:490–502.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Orefice LL, Mosko JR, Morency DT, Wells MF, Tasnim A, Mozeika SM, et al. Targeting peripheral somatosensory neurons to improve tactile-related phenotypes in ASD models. Cell. 2019;178:867–86.e824.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Penagarikano O, Abrahams BS, Herman EI, Winden KD, Gdalyahu A, Dong H, et al. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell. 2011;147:235–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references


This work was supported by the Ministry of Science and Technology of China (2021ZD0203204, 2022YFA1104003 and 2021YFC2501003) and grants from the National Natural Science Foundation of China (32030052, 31530028, 31720103908, 82230094, 81621063 and 81972616).

Author information

Authors and Affiliations



YW and HQZ conceived and supervised the project. JD and JM performed the generation and breeding of the Frmd5 knock-out mice; TJL, JM, CL, DCY, XYZ, MYW performed the behavioral, molecular and biochemical experiments; GGX, CC and NYL performed electrophysiological and morphological experiments; TJL and CL performed the proteomics experiments; XYZ, TJL, JM and YNX wrote the manuscript. All of the authors read and accepted the manuscript.

Corresponding authors

Correspondence to Yun Wang or Hong-Quan Zhang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval

All animal procedures performed in this study were approved by the Ethics Committee of Peking University Health Science Center (Beijing, China). For the data from the Decipher project, those who carried out the original analysis and collection of the data bear no responsibility for the further analysis or interpretation of the data.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lyu, TJ., Ma, J., Zhang, XY. et al. Deficiency of FRMD5 results in neurodevelopmental dysfunction and autistic-like behavior in mice. Mol Psychiatry 29, 1253–1264 (2024).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


Quick links